In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100

Trayhurn P(2001)Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60 329-339

Beattie JH(2001)Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy J Acquir Immune Defic Syndr 26 225-235

Schmitz M(2003)Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy J Clin Endocrinol Metab 88 627-636

Michl G(2003)Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 762-769

Walli R(2002)Decreased plasma adiponectin concentrations in women with dyslipidemia J Clin Endocrinol Metab 87 2764-2769

Addy CL(2005)Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes 54 795-802

Gavrila A(2004)Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice Endocrinology 145 487-494

Tsiodras S(2005)Antiretroviral treatment reduces VLDL and IDL apolipoprotein B fractional catabolic rate in HIV infected patients with mild dyslipidaemia J Clin Endocrinol Metab 90 755-760

Brodovicz K(2005)LDL apolipoprotein B metabolism in treatment naïve HIV patients and patients on antiretroviral therapy Antivir Ther 10 663-670

Karchmer AW(2003)Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy AIDS 17 1753-1762

Trayhurn P(2001)Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60 329-339

Beattie JH(2001)Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy J Acquir Immune Defic Syndr 26 225-235

Schmitz M(2003)Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy J Clin Endocrinol Metab 88 627-636

Michl G(2003)Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 762-769

Walli R(2002)Decreased plasma adiponectin concentrations in women with dyslipidemia J Clin Endocrinol Metab 87 2764-2769

Addy CL(2005)Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes 54 795-802

Gavrila A(2004)Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice Endocrinology 145 487-494

Tsiodras S(2005)Antiretroviral treatment reduces VLDL and IDL apolipoprotein B fractional catabolic rate in HIV infected patients with mild dyslipidaemia J Clin Endocrinol Metab 90 755-760

Brodovicz K(2005)LDL apolipoprotein B metabolism in treatment naïve HIV patients and patients on antiretroviral therapy Antivir Ther 10 663-670

Karchmer AW(2003)Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy AIDS 17 1753-1762